Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma
Alfasigma acquisition of Zelnorm : Alfasigma USA, a subsidiary of Italian pharmaceutical company Alfasigma, has acquired IBS-C drug Zelnorm (tegaserod), a prescription treatment for irritable bowel syndrome with constipation (IBS-C), from Sloan Pharma, a subsidiary of US WorldMeds, for an undisclosed price. Alfasigma intends to relaunch Zelnorm in the US. The IBS-C drug, which was […]